Accelerate diagnostics submits wave system and gram-negative positive blood culture menu to the fda for 510(k) clearance

Tucson, ariz. , march 21, 2025 /prnewswire/ -- accelerate diagnostics, inc. (nasdaq: axdx), an innovator in rapid in vitro diagnostics for microbiology, today announced the submission of its accelerate wave™ system and positive blood culture gram-negative test kit to the u.s. food and drug administration (fda) for 510(k) clearance.
AXDX Ratings Summary
AXDX Quant Ranking